Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by Nephros, Inc. on May 19, 2022. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes and Voting Results
Stockholders approved the following matters at the Annual Meeting:
- Election of Directors: Andrew Astor and Alisa Lask were elected to the Board of Directors for three-year terms expiring in 2025.
- Ratification of Auditors: Stockholders ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Executive Compensation: Stockholders approved the compensation of named executive officers on an advisory (non-binding) basis.
Voting Breakdown:
| Matter | For | Against/Withheld | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Election of Andrew Astor | 6,189,006 | 134,108 (Withheld) | n/a | 2,333,049 |
| Election of Alisa Lask | 6,192,377 | 130,737 (Withheld) | n/a | 2,333,049 |
| Ratification of Auditor | 8,637,438 | 17,548 (Against) | 1,177 | 0 |
| Executive Compensation | 6,093,819 | 216,653 (Against) | 12,642 | 2,333,049 |
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Key Facts for Investor Verification
- Verify the tenure of newly elected directors Andrew Astor and Alisa Lask (terms expire in 2025).
- Confirm the engagement of Baker Tilly US, LLP as the independent auditor for the 2022 fiscal year.
- Note the significant number of broker non-votes (2,333,049) on director elections and executive compensation, indicating shares held in street name where brokers lacked discretionary voting power.
- Review the company's most recent 10-K or 10-Q for financial metrics, as this 8-K contains no financial data.